Both Caffeine and Tirzepatide offer similar effectiveness, with differences in speed and duration of relief.

Tirzepatide is gentler on the liver and kidneys, making it a safer long-term option for some patients.

Caffeine has a lower risk of addiction, making it safer for patients concerned about dependency.

Both drugs are easy to use, with clear dosing schedules to ensure treatment adherence.

Both drugs have some contraindications depending on individual health conditions, but neither has major restrictions.

Both drugs are good options depending on the patient’s needs, with Caffeine better for quick relief and Tirzepatide for long-term management.